HOME >연구분야 >김헌성

김헌성

교 수 김 헌 성 Kim Hun-Sung
교수 정보
교육분야 내분비내과학, 의료정보학 TEL 02-3147-8425
연구분야 내분비내과학, 당뇨병,
이상지질혈증, 의료정보학,
디지털 헬스케어, 의료빅데이터,
실제임상근거, 비대면진료		 E-mail cadiz74@catholic.ac.kr
소속 내분비내과/의료정보학교실 연구실 이름 -

연구실 소개

연구실 소개
연구실 소개

본 연구실은 EMR data, PGHD 등의 실사용데이터(Real World Data)를 실제 진료 현장에 활용할 수 있도록 하는 연구와 ICT 기술을 의료에 접목하는 디지털 헬스케어, 비대면 진료 등에 관한 연구를 진행한다. 임상과 의료정보를 연결하여 디지털 헬스와 실사용데이터의 임상적인 활용에 많은 경험 및 다양한 임상연구 결과를 보유하고 있다.

학력

학력
연도 기관 학과 및 전공 학위
2001 인하대학교 의과대학 의학과 학사
2015 서울대학교 의과대학 의료정보학과 석·박사

경력

경력
연도 기관 직위
현재 가톨릭대학교 의료정보학교실 / 서울성모병원 내분비내과 교수
2020 ~ 2023 가톨릭대학교 의료정보학교실 / 서울성모병원 내분비내과 부교수
2016 ~ 2019 가톨릭대학교 의료정보학교실 / 서울성모병원 내분비내과 연구조교수
2013 ~ 2015 서울성모병원 내분비내과 임상조교수
2008 ~ 2012 서울성모병원 내분비내과 임상강사

학회활동 / 위촉활동

학회활동 / 위촉활동
기간 학회명 / 기관 직위
2025 ~ 현재한국보건정보통계학회고문 (26대 회장 역임)
2026 ~ 현재한국원격의료학회부회장
2026 ~ 현재심장대사증후군학회빅데이터 이사
2019 ~ 현재빅데이터임상활용연구회회장
2019 ~ 현재대한방문케어다학제학회부회장
2023 ~ 현재대한내분비학회빅데이터위원회 이사
2021 ~ 현재대한내분비학회평의원
2020 ~ 현재대한당뇨병학회평의원

대표논문

대표논문
번호 논문제목 연결
1Evaluation of the Medical Utilization of the Telemedicine Pilot Project for Patients With Diabetes Based on Korean National Health Insurance Claims Data. J Korean Med Sci. 2026;41(5):e45. 교신저자초록
2Analysis of Experiences on Telemedicine Pilot Projects from the Perspectives of Doctors, Pharmacists, and Patients. Korean J Intern Med. 2026;41(1):131-142. 교신저자초록
3Comprehensive approaches to diabetes in the elderly: adapting to evolving trends. Korean J Intern Med. 2025;40(6):1017-1028. 교신저자초록
4Evaluation of a telemedicine pilot project for hypertension in Korea: a nationwide real-world data study. Epidemiol Health. 2025;47:e2025048. 교신저자초록
5Investigation of the Impact of Body Mass Index in the 20s on Chronic Metabolic Diseases and Their Progression Rate After the Age of 65 Years. J Korean Med Sci. 2025;40:e275. 교신저자초록
6Association between metabolic dysfunction-associated steatotic liver disease and the risk of thyroid cancer: a nationwide cohort study. Korean J Intern Med. 2025;40(5):813-822. 교신저자초록
7Prevalence of Mortality and Vascular Complications in Older Patients with Diabetes in Korea. Endocrinol Metab (Seoul). 2025;40(3):448-458. 교신저자초록
8Analyzing the Current Status of the Telemedicine Pilot Project Using Korean National Health Insurance Service Data. J Korean Med Sci. 2025;40(21):e166. 교신저자초록
9Evolving Regulations in Telemedicine Pilot Project: Insights Into Law, Practice, and Patient Care through International Case Studies. J Korean Med Sci. 2025;40(23):e181. 교신저자초록
10A Pilot Study Examining If the Additional Use of a Continuous Glucose Monitoring Is Helpful for Glucose Control in Older Adults. Yonsei Med J. 2025;66:e33. 교신저자초록
11Effects of statin use on serum creatinine phosphokinase levels in normal thyroid function. Korean J Intern Med. 2024;39(4):650-658. 교신저자초록
12Dark Data in Real-World Evidence: Challenges, Implications, and the Imperative of Data Literacy in Medical Research. J Korean Med Sci. 2024;39(9):e92. 교신저자초록
13Prediction of Cardiovascular Complication in Patients with Newly Diagnosed Type 2 Diabetes Using an XGBoost/GRU-ODE-Bayes-Based Machine-Learning Algorithm. Endocrinol Metab (Seoul). 2024;39(1):176-185. 교신저자초록
14Comorbidity Patterns and Management in Inpatients with Endocrine Diseases by Age Groups in South Korea: Nationwide Data. J Pers Med. 2024;14(1):42. 교신저자초록
15Weight loss and side-effects of liraglutide and lixisenatide in obesity and type 2 diabetes mellitus. Prim Care Diabetes. 2023;17(5):460-465. 교신저자초록
16The Present and Future of Artificial Intelligence-Based Medical Image in Diabetes Mellitus: Focus on Analytical Methods and Limitations of Clinical Use. J Korean Med Sci. 2023;38(31):e253. 교신저자초록
17Long-term change in the target achievement rate of low-density lipoprotein cholesterol in patients with cardiovascular disease. Int J Clin Pharmacol Ther. 2023;61(4):159-171. 교신저자초록
18Comparison of cardiocerebrovascular disease incidence between angiotensin converting enzyme inhibitor and angiotensin receptor blocker users in a real-world cohort. J Appl Biomed. 2023;21(1):7-14. 교신저자초록
19Long-Term Risk of Cardiovascular Disease Among Type 2 Diabetes Patients According to Average and Visit-to-Visit Variations of HbA1c Levels During the First 3 Years of Diabetes Diagnosis. J Korean Med Sci. 2023;38(4):e24. 교신저자초록
20A Study on Weight Loss Caused as per the Side Effect of Liraglutide. Cardiovasc Ther. 2022;2022:5201684. 교신저자초록
21Improving Machine Learning Diabetes Prediction Models for the Utmost Clinical Effectiveness. J Pers Med. 2022;12(11):1899. 교신저자초록
22The effects and side effects of liraglutide as a treatment for obesity. Cardiovasc Prev Pharmacother. 2022;4(4):142-148. 교신저자초록
23Retrospective cohort analysis comparing changes in blood glucose level and body composition according to changes in thyroid-stimulating hormone level. J Diabetes. 2022;14(9):620-629. 교신저자초록
24Long-Term Changes in HbA1c According to Blood Glucose Control Status During the First 3 Months After Visiting a Tertiary University Hospital. J Korean Med Sci. 2022;37(38):e281. 교신저자초록
25Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes. Endocrinol Metab (Seoul). 2022;37(4):641-651. 교신저자초록
26Development of Various Diabetes Prediction Models Using Machine Learning Techniques. Diabetes Metab J. 2022;46(4):650-657. 교신저자초록
27The Impact of the Association between Cancer and Diabetes Mellitus on Mortality. J Pers Med. 2022;12(7):1099. 교신저자초록
28Development of a predictive model for the side effects of liraglutide. Cardiovasc Prev Pharmacother. 2022;4(2):87-93. 교신저자초록
29A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus. Endocrinol Metab (Seoul). 2022;37(2):195-207. 교신저자초록
30Drug Repositioning: Exploring New Indications for Existing Drug-Disease Relationships. Endocrinol Metab (Seoul). 2022;37(1):62-64. 교신저자초록
31Sodium-Glucose Cotransporter-2 Inhibitor-Related Diabetic Ketoacidosis: Accuracy Verification of Operational Definition. J Korean Med Sci. 2022;37(7):e53. 교신저자초록
32Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers: New-onset diabetes mellitus stratified by statin use. J Clin Pharm Ther. 2022;47(1):97-103. 교신저자초록
33Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research. J Lipid Atheroscler. 2022;11(2):103-110. 교신저자초록
34Scoping Review of the Literature on Smart Healthcare for Older Adults. Yonsei Med J. 2022;63(Suppl):S14-S21. 교신저자초록
35Physician Knowledge Base: Clinical Decision Support Systems. Yonsei Med J. 2022;63(1):8-15. 교신저자초록
36Association between Lung Function and New-Onset Diabetes Mellitus in Healthy Individuals after a 6-Year Follow-up. Endocrinol Metab (Seoul). 2021;36(6):1254-1267. 교신저자초록
37Data Pseudonymization in a Range That Does Not Affect Data Quality: Correlation with the Degree of Participation of Clinicians. J Korean Med Sci. 2021;36(44):e299. 교신저자초록
38Development of a Predictive Model for Glycated Hemoglobin Values and Analysis of the Factors Affecting It. Cardiovasc Prev Pharmacother. 2021;3(4):106-114. 교신저자초록
39Lack of Acceptance of Digital Healthcare in the Medical Market: Addressing Old Problems Raised by Various Clinical Professionals and Developing Possible Solutions. J Korean Med Sci. 2021;36(37):e253. 교신저자초록
40Prospect of Artificial Intelligence Based on Electronic Medical Records. J Lipid Atheroscler. 2021;10(3):282-290. 교신저자초록
41Blood Glucose Levels and Body Weight Change After Dapagliflozin Administration. Diabetes Investig. 2021;12(9):1594-1602. 교신저자초록
42Estimation of Sodium Glucose Cotransporter 2 Inhibitors-related Genital and Urinary Tract Infections Via Electronic Medical Records-based Common Data Model. J Clin Pharm Ther. 2021;46(4):975-983. 교신저자초록
43Perceptron: Basic Principles of Deep Neural Networks. Cardiovasc Prev Pharmacothers. 2021;3(3):64-72. 교신저자초록
44Towards Telemedicine Adoption in Korea: 10 Practical Recommendations for Physicians. J Korean Med Sci. 2021;36(17):e103. 교신저자초록
45Onset of Hyperkalemia Following Administration of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker. Cardiovasc Ther. 2021;2021:5935149. 교신저자초록
46Low-density lipoprotein cholesterol reduction and target achievement after switching from statin monotherapy to statin/ezetimibe combination therapy: Real-world evidence. J Clin Pharm Ther. 2021;46:134-142. 교신저자초록
47Exercise Strategies to Prevent Hypoglycemia in Patients with Diabetes. Korean J Fam Med. 2021;42(2):91-95. 교신저자초록
48Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes. Korean J Fam Med. 2021;42(4):269-273. 교신저자초록
49Analysis of Target Achievement of Low-Density Lipoprotein Cholesterol according to Age after Statin Prescription. Korean J Clin Geri. 2020;21(2):81-87. 교신저자초록
50Logistic Regression and Least Absolute Shrinkage and Selection Operator. Cardiovasc Prev Pharmacother. 2020;2(4):142-146. 교신저자초록
51Medical Ethics in the Era of Artificial Intelligence Based on Medical Big Data. J Korean Diabetes. 2020;21(3):126-129. 교신저자초록
52Out-of-Hospital Data: Patient Generated Health Data. J Korean Diabetes. 2020;21(3):149-155. 교신저자초록
53Apprehensions about Excessive Belief in Digital Therapeutics – Points of Concern Excluding Merits. J Korean Med Sci. 2020;35(45):e373. 교신저자초록
54Lessons from Use of Continuous Glucose Monitoring Systems in Digital Healthcare. Endocrinol Metab (Seoul). 2020;35:541-548. 교신저자초록
55Characteristics of Hypoglycemic Diabetic Patients Visiting the Emergency Room. Cardiovasc Ther. 2020;2020:3612607. 교신저자초록
56Changes in Target Achievement Rates After Statin Prescription Changes at a Single University Hospital. Cardiovasc Prev Pharmacother. 2020;2(3):103-111. 교신저자초록
57Discontinuation rate and reason for discontinuation after sodium glucose cotransporter 2 inhibitors prescription in real clinical practice. J Clin Pharm Ther. 2020;45:1271-1277. 교신저자초록
58Physical activity for prevention and management of sleep disturbances. Sleep Med Res. 2020;11(1):15-18. 교신저자초록
59Managing Sleep Disorders through Lifestyle Choices: A Focus on Nutrition. Korean J Clin Geri. 2020;21(1):9-15. 교신저자초록
60Lessons from Temporary Telemedicine Initiated owing to Outbreak of COVID-19. Healthc Inform Res. 2020;26(2):159-161. 교신저자초록
61Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence. Diabetes Metab J. 2020;44(4):555-565. 교신저자초록
62Decision-Making in Artificial Intelligence: Is It Always Correct? J Korean Med Sci. 2020;35(1):e1. 교신저자초록
63The short-term effects of angiotensin II receptor blockers on albuminuria and renal function in Korean patients. Basic Clin Pharmacol Toxicol. 2020;126(5):424-431. 교신저자초록
64Medical Big Data Is Not Yet Available: Why We Need Realism Rather than Exaggeration. Endocrinol Metab (Seoul). 2019;34(4):349-354. 교신저자초록
65Long-term effects of various types of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on changes in glomerular filtration rate in Korea. Front Med. 2019;13(6):713-722. 교신저자초록
66Recent Technology-Driven Advancements in Cardiovascular Disease Prevention. Cardiovasc Prev Pharmacother. 2019;1(2):43-49. 교신저자초록
67Dementia Research Using Healthcare Big Data. Dement Neurocogn Disord. 2019;18(3):73-76. 교신저자초록
68Clinical experiences and case review of angiotensin II receptor blocker-related angioedema in Korea. Basic Clin Pharmacol Toxicol. 2019;124(1):115-122. 교신저자초록
69Serum Uric Acid and Metabolic Syndrome: a Retrospective Cohort Study. J Korean Med Sci. 2019;34(48):e324. 교신저자초록
70Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE). Clin Hypertens. 2018;24:18. 교신저자초록
71Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice. Cardiovasc Ther. 2018;36(3):e12324. 교신저자초록
72Association of serum 25-hydroxyvitamin D and diabetes-related factors in Korean adults without diabetes: The Fifth Korea National Health and Nutrition Examination Survey 2010-2012. Prim Care Diabetes. 2018;12(1):59-65. 교신저자초록
73Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea. J Clin Pharm Ther. 2017;42(3):292-300. 교신저자초록
74The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients. Pharmacoepidemiol Drug Saf. 2017;26(10):1156-1163. 교신저자초록
75Analysis of National Pharmacovigilance Data Associated with Statin Use in Korea. Adverse Drug Reactions with Statins. Basic Clin Pharmacol Toxicol. 2017;121(5):409-413. 교신저자초록
76Analyzing association between low-density lipoprotein reduction by statin and adherence to medication using national health insurance service-national sample cohort (NHIS-NSC). Journal of the Korean Data & Information Science Society. 2017;28:1027-1041. 교신저자초록
77Mobile Health for Health Management of the Elderly. Korean J Clin Geri. 2016;17(1):1-6. 교신저자초록
78Modeling of Changes in Creatine Kinase after HMG-CoA Reductase Inhibitor Prescription. Cardiovasc Prev Pharmacother. 2021;3(4):115-123.초록
79Future and Development Direction of Digital Healthcare. Healthc Inform Res. 2021;27(2):95-101.초록
80Comparative analysis of the efficacy of angiotensin II receptor blockers for uric acid level change in asymptomatic hyperuricemia. J Clin Pharm Ther. 2020;45(6)1264-1270.초록
81Proceed with Caution When Using Real World Data and Real World Evidence. J Korean Med Sci. 2019;34(4):e28.초록
82Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records. J Korean Med Sci. 2018;33(34):e213.초록
83Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans. Basic Clin Pharmacol Toxicol. 2017;121(4):272-278.초록
84Comparative Analysis of the Suspected Heparin-Induced Thrombocytopenia Level in Korea. Basic Clin Pharmacol Toxicol. 2017;121(4):360-367.초록
85Analysis of inappropriate medication use and drug interactions in older people in South Korea. Int J Clin Pharmacol Ther. 2017;55(11):847-852. (co-1st author)초록
86Pilot Algorithm Designed to Help Early Detection of HMG-CoA Reductase Inhibitor-Induced Hepatotoxicity. Healthc Inform Res. 2017;23(03):199-207 (co-1st author)초록
87Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical Research. Endocrinol Metab (Seoul). 2017;32(1):90-98.초록
88Physician-Directed Diabetes Education without a Medication Change and Associated Patient Outcomes. Diabetes Metab J. 2017;41(3):187-194.초록
89Satisfaction Survey on Information Technology-Based Glucose Monitoring System Targeting Diabetes Mellitus in Private Local Clinics in Korea. Diabetes Metab J. 2017;41(3):213-222.초록
90Analysis and comparison of statin prescription patterns and outcomes according to clinical department. J Clin Pharm Ther. 2016;41(1):70-77.초록
91Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice. J Clin Pharm Ther. 2016;41(3):266-272.초록
92Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea. J Clin Pharm Ther. 2016;41(5):508-514.초록
93Comparative analysis of the efficacy of low- and moderate-intensity statins in Korea. Int J Clin Pharmacol Ther. 2016;54(11):864-871.초록
94Randomized, open-label, parallel group study to evaluate the effect of internet-based glucose management system on subject with diabetes in China. Telemedicine and e-Health. 2016;22(8):666-674.초록
95Comparing diabetic patient characteristics related to stated medication adherence in a rural vs. urban community in Korea. J Clin Pharm Ther. 2016;41(1):40-6 (Co-1st author)초록
96Social Networking Services-Based Communicative Care for Patients with Diabetes Mellitus in Korea. Appl Clin Inform. 2016;7(3):899-911.초록
97New Directions in Chronic Disease Management. Endocrinol Metab (Seoul). 2015;30(2):159-166.초록
98Current Clinical Status of Telehealth in Korea: Categories, Scientific Basis, and Obstacles. Healthc Inform Res. 2015;21(4):244-250.초록
99Using mobile phones in healthcare management for the elderly. Maturitas. 2014;79(4):381-388.초록
100Future prospects of health management system using cellular phone. Telemedicine and e-Health. 2014;20(6):544-551.초록
101Efficacy of the Smartphone-based Glucose management application according to User's satisfaction. Diabetes Metab J. 2014;38(3):204-210.초록
102Diurnal Heart Rate Variability Fluctuations in Normal Volunteers. J Diabetes Sci Technol. 2014;8(2):431-433.초록
103A Comparative Study of the Effects of a Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability in Patients with Type 2 Diabetes with Inadequate Glycemic Control on Metformin. Diabetes Technol Ther. 2013;15(10):810-6.초록
104Continuous glucose monitoring: current clinical use. Diabetes Metab Res Rev. 2012;28 Suppl 2:73-78.초록